Lv1
42 积分 2022-12-05 加入
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
18天前
已完结
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial
18天前
已完结
Drug discovery by AI trained on aging biology
21天前
已完结
Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
21天前
已完结
Molecular and Functional Characterization of the Dual‐Specificity Phosphodiesterase Type 10A in Human White Adipocytes
22天前
已关闭
Selective inhibition of phosphodiesterase 10A impairs appetitive and aversive conditioning and incentive salience attribution
22天前
已完结
Phosphodiesterase 10 Inhibitors - Novel Perspectives for Psychiatric and Neurodegenerative Drug Discovery
22天前
已关闭
Discovery and evaluation of SIPI11594: a novel mitochondrial pyruvate carrier inhibitor with anti-hair loss efficacy
29天前
已完结
Inhibition of pyruvate oxidation as a versatile stimulator of the hair cycle in models of alopecia
29天前
已完结
Targeted protein degradation: from mechanisms to clinic
1个月前
已完结
皖公网安备34019202002308
